Skip to main content
Fig. 2 | Orphanet Journal of Rare Diseases

Fig. 2

From: Clinical, biochemical and genetic spectrum of 70 patients with ACAD9 deficiency: is riboflavin supplementation effective?

Fig. 2

Age of onset, causes of death, survival and effect of riboflavin on survival of ACAD9 patients. a Age of onset of symptoms, (b) Causes of death, (c) Kaplan-Maier survival rates. In red, patients with a disease presentation in the first year of life. In blue, patients with a later presentation (p = 6.49e-05). b In red, patients with a disease presentation in the first year of life and treated with riboflavin. In blue, patients of the same age category but untreated with riboflavin (p = 5.34e-05, confidence 95%)

Back to article page